FDA Approves a New Immune-Based Treatment Option for People with Mantle Cell Lymphoma
BreakingNews_dam_file_105906.jpg
FDA Approves New Treatment for Adults with Chronic Myeloid Leukemia
FDA Approval Leukemia_0_dam_file_177331.jpg
FDA Approves Targeted Immunotherapy for Aggressive Forms of Follicular Lymphoma
BreakingNews_dam_file_105906.jpg
FDA Approves Treatment for Myelofibrosis and Anemia
FDA Approval Misc.jpg
FDA Expands Use of Leukemia Treatment to Include Children
FDA Approval Leukemia_0_dam_file_177331.jpg
FDA’s ODAC Endorses New Indications for 2 CAR-T Therapies for Myeloma
Image of a droplet_dam_file_177236.jpg
First 2025 New Blood Cancer Drug Approval Adds Years of Life for People Living with Mantle Cell Lymphoma
BreakingNews_dam_file_105906.jpg